blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP4041241

EP4041241 - METHODS FOR TREATING MYELOFIBROSIS AND RELATED CONDITIONS [Right-click to bookmark this link]
StatusExamination is in progress
Status updated on  22.08.2024
Database last updated on 14.09.2024
FormerRequest for examination was made
Status updated on  15.07.2022
FormerThe international publication has been made
Status updated on  03.04.2021
Most recent event   Tooltip24.08.2024New entry: Despatch of examination report + time limit 
Applicant(s)For all designated states
Disc Medicine, Inc.
321 Arsenal Street, Suite 101
Watertown, MA 02472 / US
[2022/33]
Inventor(s)01 / QUISEL, John
150 Cambridgepark Drive Suite 103
Cambridge, MA 02140 / US
02 / BECONI, Maria
150 Cambridgepark Drive Suite 103
Cambridge, MA 02140 / US
03 / ROBINETTE, Steven
89 Scribner Road
Fremont, NH 03044 / US
04 / MACDONALD, Brian
19 Paper Mill Rd
Newton Square, PA 19073 / US
 [2022/33]
Representative(s)Atkins, James Gordon John, et al
Kilburn & Strode LLP
Lacon London
84 Theobalds Road
London WC1X 8NL / GB
[2022/33]
Application number, filing date20867029.925.09.2020
[2022/33]
WO2020US52732
Priority number, dateUS201962907227P27.09.2019         Original published format: US 201962907227 P
US202063063761P10.08.2020         Original published format: US 202063063761 P
US202063072057P28.08.2020         Original published format: US 202063072057 P
[2022/33]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2021062163
Date:01.04.2021
Language:EN
[2021/13]
Type: A1 Application with search report 
No.:EP4041241
Date:17.08.2022
Language:EN
The application published by WIPO in one of the EPO official languages on 01.04.2021 takes the place of the publication of the European patent application.
[2022/33]
Search report(s)International search report - published on:US01.04.2021
(Supplementary) European search report - dispatched on:EP07.08.2023
ClassificationIPC:A61K31/519, A61K39/00, A61K39/395, A61K45/00, A61K45/06, A61P29/00, A61P7/06, C07K16/28, // A61K38/00
[2023/36]
CPC:
C07K16/28 (EP,IL,KR,US); A61K38/1709 (KR); A61K31/454 (KR);
A61K31/55 (KR); A61K38/00 (EP,IL); A61K38/1816 (KR);
A61K39/3955 (US); A61K45/06 (KR,US); A61P7/06 (EP,IL,KR,US);
A61K2039/505 (EP,IL,KR,US); C07K2317/33 (EP,IL,KR); C07K2317/76 (EP,IL,KR) (-)
Former IPC [2022/33]A61K31/519, A61K39/00, A61K39/395, A61K45/00, A61K45/06, A61P29/00
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2022/33]
TitleGerman:VERFAHREN ZUR BEHANDLUNG VON MYELOFIBROSE UND VERWANDTEN ERKRANKUNGEN[2022/33]
English:METHODS FOR TREATING MYELOFIBROSIS AND RELATED CONDITIONS[2022/33]
French:PROCÉDÉS DE TRAITEMENT DE LA MYÉLOFIBROSE ET D'AFFECTIONS ASSOCIÉES[2022/33]
Entry into regional phase26.04.2022National basic fee paid 
26.04.2022Search fee paid 
26.04.2022Designation fee(s) paid 
26.04.2022Examination fee paid 
Examination procedure26.04.2022Examination requested  [2022/33]
04.03.2024Amendment by applicant (claims and/or description)
04.03.2024Date on which the examining division has become responsible
23.08.2024Despatch of a communication from the examining division (Time limit: M04)
Fees paidRenewal fee
27.09.2022Renewal fee patent year 03
27.09.2023Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[Y]US2008213277  (SASU BARBRA [US], et al) [Y] 2 * entire document *;
 [A]US7968091  (WOOLF CLIFFORD J [US], et al) [A] 1-6, 18-21, 80-93* entire document *;
 [A]US9315577  (FOLTZ IAN [CA], et al) [A] 1-6, 18-21, 80-93 * entire document *;
 [A]US2017313754  (BOURNE GREGORY THOMAS [AU], et al) [A] 1-6, 18-21, 80-93 * entire document *;
 [Y]US2018016332  (SCHURPF THOMAS [US], et al) [Y] 21 * entire document *;
 [XY]US2018050085  (KUMAR RAVINDRA [US], et al) [X] 1, 3-6, 80-82, 86, 87, 89, 91-93 * entire document * [Y] 2, 18-21, 83-85, 88, 90;
 [Y]US2018057812  (PEYSSONNAUX CAROLE [FR], et al) [Y] 18-21 * entire document *;
 [Y]US10246462  (BECK HILARY PLAKE [US], et al) [Y] 88, 90 * entire document *;
 [Y]  - Heinz Zoller, Theurl Igor, "Iron in Cancer, Infection, Kidney and Liver diseases: Innocent bystander or therapeutic target?", Bio Iron, (20190505), pages 1 - 67, URL: https://bioironforum.org/wp-content/uploads/2018/10/7.-Iron-in-cancer-infection-kideny-and-liver-diseases.Theurl-Zoller.pdf, (20200915), XP055730962 [Y] 83 * . entire document *
 [Y]  - Kovac Suzana, Preethne Böser, Yifang Cui, Dunja Ferring-Appel, Daniela Casarrubea, Lili Huang, Emma Fung, Andreas Popp, Bernhard K. Mueller,, "Anti-Hemojuvelin Antibody Corrects Anemia Caused by Inappropriately High Hepcidin Level", Haematologica, (20160501), vol. 101, no. 5, pages e173 - e176, XP055806880 [Y] 84, 85 * . entire document *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.